查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049564

新冠病毒診斷市場報告：按產品類型、檢體類型、測試類型、模式、最終用途和地區分類（2026-2034 年）

COVID-19 Diagnostics Market Report by Product Type, Sample Type, Test Type (Molecular Testing, Antigen-based Testing, Antibody Testing, and Others), Mode (Point-of-Care, Non-Point-of-Care ), End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球新冠病毒診斷市場規模達541億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到281億美元。

新冠病毒感染診斷是指透過臨床檢測來判斷個體是否感染新冠病毒。新冠病毒感染是由一種新發現的通用冠狀病毒感染疾病的感染疾病。常見症狀包括發燒、疲倦、乾咳、呼吸急促、喉嚨痛和全身酸痛。這種病毒感染疾病通常透過逆轉錄聚合酵素鏈鎖反應（RT-PCR）、抗原檢測和抗體檢測進行診斷。這些檢測使用試劑盒和試劑盒採集檢體咽拭子、口咽拭子、唾液或血液樣本。這些檢測方法廣泛應用於醫院、檢查室、診所、研究機構和診斷中心。

新冠病毒感染疾病的突然爆發以及全球新冠肺炎病例的驚人成長是推動市場成長的關鍵因素。每日新增病例的持續攀升促使診斷檢測被廣泛採用，作為一種快速、全面的手段，以便為患者提供早期治療。這導致大規模檢測和分子診斷的需求增加，從而促進了市場成長。此外，各種產品創新，例如檢測套組居家檢測的新型抗體和血清學檢測套組的推出，也正在推動市場成長。與傳統檢測套組相比，這些產品速度更快，並且可以與軟體程式整合以獲得更準確的結果。預計推動市場成長的其他因素還包括政府為防止新冠肺炎疫情進一步蔓延而採取的有利政策，以及醫療基礎設施的顯著改善，尤其是在開發中國家。

本報告解答的主要問題

  • 2025年全球新冠病毒診斷市場規模將達到多少？
  • 新冠疫情對全球新冠病毒診斷市場產生了哪些影響？
  • 推動全球新冠病毒診斷市場發展的主要因素是什麼？
  • 全球新冠病毒診斷市場按產品類型分類的情況如何？
  • 全球新冠病毒診斷市場依檢體類型分類的情況如何？
  • 全球新冠病毒診斷市場按檢測類型分類的情況如何？
  • 全球新冠病毒診斷市場依檢測方式分類是怎樣的？
  • 全球新冠病毒診斷市場依最終用途分類是怎樣的？
  • 全球新冠病毒診斷市場的主要區域有哪些？
  • 全球新冠病毒診斷市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球新冠病毒診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 試劑和試劑盒
  • 裝置
  • 其他

第7章 市場區隔：依檢體類型

  • 鼻咽拭子
  • 口腔和咽拭子
  • 鼻拭子
  • 血
  • 其他

第8章 市場區隔：依測試類型分類

  • 分子（RT-PCR）檢測
  • 抗原檢測
  • 抗體（血清學）檢測
  • 其他

第9章 市場細分：依模式

  • 即時偵測 (PoC)
  • 非即時檢測（PoC）

第10章 市場區隔：依最終用途分類

  • 研究所
  • 醫院
  • 診斷中心和診所
  • 其他

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢與預測
    • 市場細分：按國家/地區

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章：價格分析

第16章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories
    • Danaher Corporation
    • F. Hoffman-La Roche Ltd.（Roche Holding AG）
    • Luminex Corporation
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Robert Bosch GmbH
    • Seegene Inc.
    • Siemens Aktiengesellschaft
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A3552

The global COVID-19 diagnostics market size reached USD 54.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 28.1 Billion by 2034.

COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.

KEY MARKET SEGMENTATION:

Breakup by Product Type:

  • Reagents and Kits
  • Instruments
  • Others

Breakup by Sample Type:

  • Nasopharyngeal Swabs
  • Oropharyngeal Swabs
  • Nasal Swabs
  • Blood
  • Others

Breakup by Test Type:

  • Molecular (RT-PCR) Testing
  • Antigen-based Testing
  • Antibody (Serology) Testing
  • Others

Breakup by Mode:

  • Point-of-Care (PoC)
  • Non-Point-of-Care (Non-PoC)

Breakup by End Use:

  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global COVID-19 diagnostics market in 2025?
  • 2.What has been the impact of COVID-19 on the global COVID-19 diagnostics market?
  • 3.What are the key factors driving the global COVID-19 diagnostics market?
  • 4.What is the breakup of the global COVID-19 diagnostics market based on the product type?
  • 5.What is the breakup of the global COVID-19 diagnostics market based on the sample type?
  • 6.What is the breakup of the global COVID-19 diagnostics market based on the test type?
  • 7.What is the breakup of the global COVID-19 diagnostics market based on the mode?
  • 8.What is the breakup of the global COVID-19 diagnostics market based on the end use?
  • 9.What are the key regions in the global COVID-19 diagnostics market?
  • 10.Who are the key players/companies in the global COVID-19 diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COVID-19 Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends and Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends and Forecast
  • 6.3 Others
    • 6.3.1 Market Trends and Forecast

7 Market Breakup by Sample Type

  • 7.1 Nasopharyngeal Swabs
    • 7.1.1 Market Trends and Forecast
  • 7.2 Oropharyngeal Swabs
    • 7.2.1 Market Trends and Forecast
  • 7.3 Nasal Swabs
    • 7.3.1 Market Trends and Forecast
  • 7.4 Blood
    • 7.4.1 Market Trends and Forecast
  • 7.5 Others
    • 7.5.1 Market Trends and Forecast

8 Market Breakup by Test Type

  • 8.1 Molecular (RT-PCR) Testing
    • 8.1.1 Market Trends and Forecast
  • 8.2 Antigen-based Testing
    • 8.2.1 Market Trends and Forecast
  • 8.3 Antibody (Serology) Testing
    • 8.3.1 Market Trends and Forecast
  • 8.4 Others
    • 8.4.1 Market Trends and Forecast

9 Market Breakup by Mode

  • 9.1 Point-of-Care (PoC)
    • 9.1.1 Market Trends and Forecast
  • 9.2 Non-Point-of-Care (Non-PoC)
    • 9.2.1 Market Trends and Forecast

10 Market Breakup by End Use

  • 10.1 Laboratories
    • 10.1.1 Market Trends and Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends and Forecast
  • 10.3 Diagnostic Centers and Clinics
    • 10.3.1 Market Trends and Forecast
  • 10.4 Others
    • 10.4.1 Market Trends and Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends and Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends and Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends and Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends and Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends and Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends and Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends and Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends and Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends and Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends and Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends and Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends and Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends and Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends and Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends and Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends and Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends and Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends and Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends and Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends and Forecast
    • 11.5.2 Market Breakup by Country

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 bioMerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Danaher Corporation
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Luminex Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics Incorporated
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Robert Bosch GmbH
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Seegene Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Siemens Aktiengesellschaft
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2025
  • Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2025
  • Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2025
  • Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2025
  • Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million USD), 2026-2034
  • Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2026-2034
  • Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
  • Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
  • Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million USD), 2026-2034
  • Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million USD), 2026-2034
  • Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
  • Table 9: Global: COVID-19 Diagnostics Market: Key Players